Saturday, October 3, 2026

EUR/CHF Over 1% Down In The Last 21 Sessions

ViaNews Editorial Team

February 7, 2023

EUR/CHF Over 1% Down In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.51% for the last 21 sessions. At 05:07 EST on Tuesday, 7 February, EUR/CHF (EURCHF) is $0.99.

EUR/CHF's yearly highs and lows, it's 5.186% up from its 52-week low and 6.531% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.45%, a positive 0.02%, and a positive 0.29%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.45% (last week), 0.34% (last month), and 0.29% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy: the ingredients are in place for a renewed move lower – HSBC. According to FXStreet on Monday, 6 February, "A move lower in USD/JPY over the coming few weeks will mostly rely on the outlook for BoJ policy change, but other more medium-term forces (such as improving current account balance) should also be helping in the background."
  • Usd/jpy price analysis: bulls move in and target 133.00 ahead of the 200-dma. According to FXStreet on Monday, 6 February, "The USD/JPY shifted neutral biased after gapping up from around 131.20 to current exchange rates. ", "Therefore, the USD/JPY rallied 3.45% since Friday and exchanged hands at 132.79after hitting a low of 131.51."
  • Usd/jpy skids below 132.50 as boj confirms stealth intervention. According to FXStreet on Tuesday, 7 February, "The USD/JPY pair has slipped below the immediate cushion of 132.50 in the Asian session. ", "On the Japanese Yen front, the stealth intervention by the BoJ might have been conducted amid fresh concerns that further interest rate hikes by the Fed will weaken the USD/JPY broadly."
  • Usd/jpy eases from multi-week top, bullish potential intact amid post-nfp USD strength. According to FXStreet on Monday, 6 February, "The USD/JPY pair struggles to capitalize on its modest bullish gap opening and retreats a few pips from over a three-week high touched earlier this Monday. ", "Apart from this, the broader risk sentiment will drive demand for the safe-haven JPY and contribute to producing short-term opportunities around the USD/JPY pair."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com